ScienceDex / Researcher record
Juan Marugan
- National Center for Advancing Translational Sciences (no department on record)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
- Top 10% Funded
- Early Career
NIH Funding · FY2025
Award data coverage
One fiscal year is available for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2025): $5.2M in linked award amounts across 15 award records · Award-linked rank #1288.
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2025 · selected15 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 14380300Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2025 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2025 award records by amount
NIH award records listing Juan Marugan as a PI. Multi-PI records show the full award amount for context.
- 1ZIATR000083-11ZIAContact PIIdentification of small molecule that selectively modulate Ghrelin receptor (GHSR1a) b-arrestin signaling as a new therapeutic approach for the treatment of addiction$418.4Kaward amount
- 1ZIATR000086-11ZIAContact PIIdentification of novel agonist of the Relaxin family peptide receptor 2 (RXFP2) as potential new therapeutics for testicular maldescent$418.4Kaward amount
- 1ZIATR000096-11ZIAContact PIPAC1 receptor antagonists as potential treatments for depression and atherosclerosis associated with chronic stress$418.4Kaward amount
- 1ZIATR000209-11ZIAContact PISmall molecule agonists of the relaxin 1 receptor$418.4Kaward amount
- 1ZIATR000212-11ZIAContact PIDiscovery of Novel Modulators of the Human D2 Dopamine Receptor$418.4Kaward amount
- 1ZIATR000267-10ZIAContact PIMedicinal chemistry campaign to synthesize synaptamide analogs (GPR110)$418.4Kaward amount
- 1ZIATR000302-09ZIAContact PICD206 activators as novel immunomodulators$418.4Kaward amount
- 1ZIATR000432-05ZIAContact PIEvaluation of cAbl allosteric inhibitors in Gaucher-Parkinson$418.4Kaward amount
- 1ZIATR000203-11ZIAContact PIHTS to Identify Inhibitors of c-Abl kinase for the Potential Treatment of Epilepsy and Neurodegenerative diseases$418.4Kaward amount
- 1ZIATR000208-11ZIAContact PIProgression of Metarrestin that Reduces PNC Prevalence and Elucidation of its Mechanism of Action$418.4Kaward amount
+5 more grants not shown.
Award organization
Organizations that administered FY2025 awards listing Juan Marugan as a PI.
FY2025 award administered by National Center for Advancing Translational Sciences ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2025First NIH AwardNational Center for Advancing Translational Sciences
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025$5M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #1288
- 2025Entered Top 25% NationallyRanked #1288
- 2025Entered Top 10% NationallyRanked #1288